Here are articles from the latest issue of American Health & Drug Benefits. AHDB is the peer-reviewed journal for 30,000 decision makers in health plans, PBMs, Medicare, Medicaid, and the pharma and biotech industries:
May 2009 Issue:
The Paradox of Public Policy Reform: Change or Continuum?
By Robert E. Henry
Are You Kidding Me? Clinical Comparative Effectiveness or Evidence-Based Medicine
By Thomas Kaye RPh, MBA, FASHP
MIPPA: First Broad Changes to Medicare Part D Plan Operations
By Jean D. LeMasurier and Babette Edgar, PharmD, MBA
Stakeholder Perspective by Mark Newsom, MSc
Interview with Ronald A. Paulus, MD, MBA
By Matias A. Klein
By Melinda C. Haren, RN; Kirk McConnell; Arthur F. Shinn, PharmD, FASCP
Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA
New Legislations on Generics and Biosimilars Brewing in Congress
By Dalia Buffery, MA, ABD
Paying for Cancer Care: Economic Models Start to Emerge, Dovetailing Healthcare Reform
By Caroline Helwick
Read Current and Past Issues:
American Health & Drug Benefits (AHDB) is available in print and online at www.AHDBonline.com. To view the current or past issues, click here.
AHDB also published web exclusives, available for reading here.
Kip Piper is health policy editor of American Health & Drug Benefits.